Diabetic CKD — RCPSC IM MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: C — Add an SGLT2 inhibitor for kidney and cardiovascular protection
Albuminuric diabetic CKD despite RAAS blockade is an indication for SGLT2 inhibitor therapy if eGFR and tolerability permit, for kidney and cardiovascular protection beyond glycemic lowering.
Reference: Diabetes Canada CKD in diabetes 2025 update; KDIGO 2024 CKD guideline